Novo Nordisk Foundation establishes Danish Diabetes and Endocrine Academy
A new grant from the Novo Nordisk Foundation has been used to establish a new educational facility which will aim to improve the quality of Danish research and teaching within diabetes and endocrinology.
by andreas lønstrup, translated by catherine brett
The Novo Nordisk Foundation has granted DKK 195m (USD 27m) to establish the Danish Diabetes and Endocrine Academy (DDEA).
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Novo Holdings portfolio company sold to US buyer
For subscribers
GSK to invest USD 1.2bn in infectious disease battle
For subscribers
